Skip to content
10-Q

Quarterly Report

LEXARIA BIOSCIENCE CORP. LEXX

0001640334-25-000629

← back to feed
Filed
Apr 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Apr 14, 2025 17.56M sh
Cash And Equivalents Q2 2025 · Feb 28, 2025 $6.5M
Stockholders Equity Q2 2025 · Feb 28, 2025 $7.14M
Stockholders Equity Q2 2025 · Aug 31, 2024 $8.04M
Current Liabilities Q2 2025 · Feb 28, 2025 $1.82M
Current Liabilities Q2 2025 · Aug 31, 2024 $1.1M
Total Liabilities Q2 2025 · Feb 28, 2025 $1.92M
Total Liabilities Q2 2025 · Aug 31, 2024 $1.21M
Current Assets Q2 2025 · Feb 28, 2025 $7.72M
Current Assets Q2 2025 · Aug 31, 2024 $7.9M
Total Assets Q2 2025 · Feb 28, 2025 $8.68M
Total Assets Q2 2025 · Aug 31, 2024 $8.87M
Net Income Q2 2025 · Nov 30, 2024 −$2.7M
Net Income Q2 2025 · Feb 29, 2024 −$649.54K
Net Income Q2 2025 · Feb 29, 2024 −$1.83M
Net Income Q2 2025 · Nov 30, 2023 −$1.18M
Shares Diluted Q2 2025 · Feb 29, 2024 10.77M sh
Shares Diluted Q2 2025 · Feb 29, 2024 9.97M sh
Capex Q2 2025 · Feb 29, 2024 $0
Operating Cash Flow Q2 2025 · Feb 29, 2024 −$1.8M
Eps Diluted Q2 2025 · Feb 29, 2024 −$0.06
Eps Diluted Q2 2025 · Feb 29, 2024 −$0.18
Sga Expense Q2 2025 · Feb 29, 2024 $567.23K
Sga Expense Q2 2025 · Feb 29, 2024 $1.28M
Rd Expense Q2 2025 · Feb 29, 2024 $245.78K
Rd Expense Q2 2025 · Feb 29, 2024 $820.27K
Operating Income Q2 2025 · Feb 29, 2024 −$668.01K
Operating Income Q2 2025 · Feb 29, 2024 −$1.81M
Gross Profit Q2 2025 · Feb 29, 2024 $145K
Gross Profit Q2 2025 · Feb 29, 2024 $291.46K